Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and ... Read More
-
Medical Imaging Equipment Services
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Equipment Repair & Maintenance Services, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$17.9 ... Read More
-
Fetal Monitoring
... CAGR of 6.1% over the analysis period 2024-2030. Ultrasound Systems, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
-
Image Guided Surgery Devices
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.4 Million by the end ... Read More
-
Computed Tomography (CT) Scanners
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. High-End Slice Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Single Photon Emission Computed Tomography (SPECT)
... reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Standalone SPECT, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Ancestry & Relationship Testing, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.3 Billion ... Read More
-
Scintillators
... 4.9% over the analysis period 2024-2030. Inorganic Scintillators, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$492.3 Million by the end of the analysis period. Growth ... Read More
-
Clinical Chemistry Analyzers
... at a CAGR of 4.9% over the analysis period 2024-2030. Clinical Chemistry Analyzer Reagents, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$12.5 Billion by the ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the ... Read More
-
Automated Blood Tube Labelers and Specimen Transport Boxes
... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a ... Read More
-
Pathology Instruments
... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Cancer / Tumor Profiling
... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 ... Read More
-
Intravascular Ultrasound (IVUS)
... at a CAGR of 7.7% over the analysis period 2024-2030. IVUS Catheters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$659.0 Million by the end of ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Tissue Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Plastic Films
... CAGR of 5.8% over the analysis period 2024-2030. LLDPE Material, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Cardiac POC Testing Devices
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More
-
Lateral Flow Assays
... at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end ... Read More
Research Assistance
